01—History
Net Income History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $313.7M
2 older moves run past ±150% (largest −303.9%); point at, tap or drag across the bars to read one.
02—Ledger
Net Income, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $313.7M | +212.8% | 10-K | |
| FY2024 | −$278.2M | +36.8% | 10-K | |
| FY2023 | −$440.2M | +61.1% | 10-K | |
| FY2022 | −$1.13B | −32.6% | 10-K | |
| FY2021 | −$852.8M | +0.6% | 10-K | |
| FY2020 | −$858.3M | +3.1% | 10-K | |
| FY2019 | −$886.1M | −16.4% | 10-K | |
| FY2018 | −$761.5M | −55.1% | 10-K | |
| FY2017 | −$490.9M | −19.7% | 10-K | |
| FY2016 | −$410.1M | −41.4% | 10-K | |
| FY2015 | −$290.1M | +19.5% | 10-K | |
| FY2014 | −$360.4M | −303.9% | 10-K | |
| FY2013 | −$89.2M | +15.8% | 10-K | |
| FY2012 | −$106.0M | −83.9% | 10-K | |
| FY2011 | −$57.6M | −32.5% | 10-K | |
| FY2010 | −$43.5M | +8.6% | 10-K | |
| FY2009 | −$47.6M | −81.3% | 10-K | |
| FY2008 | −$26.2M | — | 10-K |
03—Questions
What is net income?
Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.
What is ALNYLAM PHARMACEUTICALS, INC.'s current net income?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual net income for 2025 was $313.7M, a 212.79% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. net income for the quarter ending December 31, 2025 was $147.2M.
What was ALNYLAM PHARMACEUTICALS, INC.'s net income in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual net income for 2024 was $-278.2M, a 36.82% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s net income in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual net income for 2023 was $-440.2M, a 61.08% increase from 2022.
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Ticker
- ALNY
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations